Highest Score

Ranked by analysis score
Ranks this page's recent reports by score.
Parsons Corporation
PSN·Technology
A ★★★★Buy
Current$50.69
Target$61.20
Return+20.7%
Nov 2, 2026

Parsons offers discounted exposure to long-term defense technology and infrastructure demand, supported by record backlog and resilient cash flow, although federal contract volatility and weak capital returns could delay earnings recovery.

Score
81
Stryker Corporation
SYK·Healthcare
A ★★★★Buy
Current$291.86
Target$338.10
Return+15.8%
Nov 1, 2026

Stryker combines a durable medical-device franchise, strong cash generation and a historically compressed valuation, but weaker guidance, cybersecurity exposure and acquisition impairments challenge near-term earnings confidence.

Score
81
Itron, Inc.
ITRI·Technology
A ★★★★Buy
Current$95.82
Target$116.00
Return+21.1%
Nov 1, 2026

Itron offers durable smart-grid infrastructure exposure, growing recurring software revenue and attractive cash-flow valuation, although acquisition execution and uneven utility deployment cycles could constrain earnings growth.

Score
81
Expedia Group, Inc.
EXPE·Consumer Discretionary
A ★★★★Buy
Current$285.93
Target$315.00
Return+10.2%
Nov 1, 2026

Expedia combines a profitable global travel marketplace with fast-growing B2B distribution and attractive forward earnings valuation, although search competition, travel cyclicality, and working-capital volatility could limit returns.

Score
81
Gaming and Leisure Properties, Inc.
GLPI·Real Estate
A ★★★★Buy
Current$38.98
Target$47.30
Return+21.3%
Nov 1, 2026

GLPI offers high recurring rental income, an attractive dividend yield, and potential valuation recovery as new casino investments mature, though tenant concentration, leverage, and development execution remain important risks.

Score
81
Verisk Analytics, Inc.
VRSK·Industrials
A ★★★★Buy
Current$196.30
Target$213.75
Return+8.9%
Nov 1, 2026

Verisk combines a durable insurance data moat, exceptional cash conversion, and a historically discounted valuation, although the unresolved AccuLynx acquisition threatens financial flexibility and capital-allocation returns.

Score
81
Carlisle Companies Incorporated
CSL·Industrials
A ★★★★Buy
Current$376.31
Target$432.00
Return+14.8%
Oct 31, 2026

Carlisle combines a high-ROIC commercial roofing franchise with resilient replacement demand and significant share repurchases, but petroleum-based input inflation and construction weakness could delay margin recovery.

Score
81
Kirby Corporation
KEX·Industrials
A ★★★★Buy
Current$143.93
Target$168.00
Return+16.7%
Oct 31, 2026

Kirby combines a scale-advantaged domestic tank-barge franchise with expanding power-generation demand and strong cash returns, although cyclical freight markets, fuel inflation, and capital intensity constrain its long-term upside.

Score
81
Encompass Health Corporation
EHC·Healthcare
A ★★★★Buy
Current$135.90
Target$149.10
Return+9.7%
Oct 31, 2026

Encompass Health can compound earnings through growing rehabilitation demand, hospital expansion, and operating leverage, although reimbursement constraints, labor inflation, and heavy capital spending limit its valuation margin of safety.

Score
81
Sensata Technologies Holding plc
ST·Technology
A ★★★★Buy
Current$41.30
Target$48.72
Return+18.0%
Oct 30, 2026

Sensata offers attractive cash-flow valuation and improving industrial earnings supported by embedded sensor franchises and deleveraging, although automotive cyclicality and canceled EV programs threaten recurring growth.

Score
81
SK hynix Inc.
SKHY·Technology
A ★★★★Buy
Current$162.09
Target$210.00
Return+29.6%
Oct 30, 2026

SK hynix combines HBM technology leadership, exceptional AI memory demand, and strong cash generation with attractive normalized earnings potential, although semiconductor cyclicality and rising competition threaten the durability of peak margins.

Score
81
Agree Realty Corporation
ADC·Real Estate
A ★★★★Buy
Current$67.61
Target$77.12
Return+14.1%
Oct 30, 2026

Agree Realty offers durable net-lease income, high occupancy, and modestly attractive AFFO valuation with long-term dividend growth potential, although equity dilution and elevated financing costs could constrain per-share compounding.

Score
81